Posted by Michael Wonder on 28 Jul 2018
Other countries are getting a 'free ride' on prescription drug prices, says former pharma executive
27 July 2018 - Prescription drugs from the United States, with its innovative technology, are something other countries want and should pay for, Hassan says.
Perhaps other countries should be paying more for America's innovative prescription drugs, former pharmaceutical executive Fred Hassan told CNBC.
"A lot of wealthy countries, including our neighbour to the north, a lot of the countries in Western Europe, Japan, they should be paying more," Hassan, former chairman and CEO of Schering-Plough, which was acquired by Merck in 2009, said Friday on "Power Lunch."
